Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection
Zeinab Aryanian, Kamran Balighi, Parvaneh Hatami, Nasim Tootoonchi, Azadeh Goodarzi, Zeinab Mohseni Afshar
Abstract
Although the presence of morphea following COVID-19 has been rarely reported, the development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with.
Topics & Concepts
MedicineMorpheaVaccinationCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyVirologyViral infection2019-20 coronavirus outbreakImmunologyVirusPathologyOutbreakDiseaseInfectious disease (medical specialty)Lichen sclerosusSystemic Sclerosis and Related DiseasesDermatological and COVID-19 studiesAutoimmune Bullous Skin Diseases